Philip Morris
the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
Fields
- Author
- Eckfeldt, J.
- Evans, G.
- Heiss, G.
- Howard, G.
- Szklo, M.
- Tell, G.
- Evans, G.
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- ABST, ABSTRACT
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Named Organization
- American Heart Assn
- Author (Organization)
- Arteriosclerosis + Thrombosis
- Bowman Gray School of Med Winston Salem
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ojc02a00
Document Images
1432a Arterioacleroals and Thrombosis Vol 11, No 5 Seprer8ber/ocrober 1991
.-V
:
t
gene expression in cynomolgtu monkeys, that IL-1$ is ex-
pressed in both early and advanced stagas of diet-indueed
atherosclerosis, as well as in monkey monocytesJmacrophages,
and suggest that this model can be employed to study the role
of 1L-1S in atharogenesis.
Extensf.e Oxidation of LDL Induces Particle At[re6atloa and
Altered Maeroprtage Beoognitiba
Henry F. Hoff, Todd E. Whitaker, and7une O'Neil
Research /n.vinae, Cle+.eland Cfinic Fouedanon, Cleurlend,Ohio
Although studies have reported structural and functional
changes in LDL following oaidation:(ox-), none have described
such changes with increasing degrees of ox. We describe
time-dependent changes in chemical and structural eomposi-
tion of ox-LDL and htrr they affect macrophage interaction.LDL (500 µg/ml) was incubated with
10:µM Clt" at20`C for
up to 25 hr. Time-dependentincreases in conjugated'dienesd fluoroscence (36ckx/430em), and particle
aggregation (aggr.)
were found, the latter increasing with LDL concentration
used: Similar degrees of LDL ox. gave fragments of apo B of
the same size. Extensive LDL ox. induced aggr. of apa B,
possibly'caused by covalent aou-linking of apo$. since apo B
from aggr. ox-LDL but not from vonea-aggr. LDL was insol-
ublc in SDS. Mildly ox-LDL cg. 8 hr in Cu' °(unaggr.) and the
soluble portion of extensively ox-LDL (25 hr), were recognized
by the scavenger receptor on mouse peritoneal maaophagee,.
(inhibition of `1-oo-LDL macrophase degradation by aceryl
LDL). By contract, neither accryl-LDL nor polyinosinic acid
inhibited macrophage degradation of aggr. ox-LDL suggesting
internalization by an alternate process. Thus, ox. of LDL leads
to ditTerenu structural' and' functional I eharacteriatics- depend-
ing on the degree of ox.
Identiflcation of a Lipid-Fre.e Apo(al-Apo B Complex In the
d> 2.2 Frsttion er Plasma
Akira Yashiro, June O'Neil. and Henry F. Hoff
Reseuxh /nsntutt Clevrfand Clinic foundaffon. ClttYland, Oliio
Although studies have reported the binding of apo(a)-apo
B complcxes eg.. 1a'1-B to different lipoprotein species. iden-
t'iticsnon of lipid-free (a),B in plasma has not been reportcd;
To identify such compicxes, we subjeaed! human plasma to
denaitv gradient ultraccntrifugation and documented lmmu-
norcactivc apo(a/ and apo B in the d> 1.2 fraction by appro-
priate RIAs. Morerwer (a)-B was similar to delipidated Lp(a)
in tr, agarose electroplinresis: On non-denaturing PAGE
(S:S-7S % gradient), an MW of, l0'KD was found for the
apu(ia)-B complex. On SDS-PAGE, one major band was
found under non-reducing conditions which imrnunostained
for both apo(a) and apo B. Under reducing conditions, two
major bands were .een, one staining for apo(a) and one for
apn B. (a)-B from the d> li2 plasma fraction bound and could
he elutad'from a Scpharose-anti-apo(a) column. This fraction
containing only apo(a)land apo B, was lipid flree, and mim-
ici;e& d'elipidated Lp(a) by the above-describcd procedures.
Thux, plasma contains a lipid-free apo(a)--apo B complex that
could bind' under specific metabolic conditions to different
lipoprotcin fractions.
5omatostatin and its Analogue. Angiopeptia. Inhibit Adhesion
of Leukocytes to ttat Heart Endothellal Cells
Dariusz Leazczynaki. Michael, D. Josephs.,Roben S. Fournier6
and Marie L. Foegh
GeorFrraKr Unimrstrv Medlcal'Ctnttr. WashutRron, D:C..
The effect of somauxtatin (ST) andIts analogue Angiopep-
tin (AP) on in tMrro adhesion of rat spleen Ieukocytes (LC) to
uncumulated and IL-Ib stimulued rat hean endothelial eollt
(EC) was studied. ST and AP inhibited LC adhesion to EC.
The strnnttest inhibition was observed after 24 hours exposure.
ti,. 1, iu ''S `1 t~
~
Unstimutated EC bound 208x89 LCJmm'. Trcatment,wiih ST
or AP (0.6-10 ALM)~ for 24h decreased btnding to 124_1:5
LC/t4tmt'and 11g=60, LCJirtm=. respectively (p<U.00!): EC
stimulated for 4h with IL-lb (100U/m1) bound )045=3'_ LC/
mm': ST (0.6 satyt) reduced' binding to 292x31 LGmm'
(p<0.01). AP (1' µJvf)Iwas less potent and'reduced binding to
811s75 LGmm? (p<0.125). However, affect of AP was longer
lasting (up to 24h). in conclusion. Angiopeptin may have a
potential application in immune relatcd cardiac vascular dis-
ease due to its prolonged inhibitory effect on IL-lb induced
LC-EC adhesion.
Plasma L/poproteins Specifically Bind Tbrombospondin
('CSP)
Akihiko Muraishi: Maria A. Kowa)aka, Vicki~ R. Rothman,
David M. Capuui, and George P. Tusrynskil
Deparrment ojMedic,ne. Medlcal Collegc of Pennsvfvania. Phfl=
adelphia, Pa.
The present study' explored the potential I interaction be-
tween TSP and plasma lipoproteins using an Ut virro binding
assay, Human plasma lipoproteins VLDL, LDL HIDL and
apolipoproteins Al and All were immobilized on microtitsr
plates and TSP binding was deterrnined' tmmunochemcally
with a polyclonal anti-TSP antibody. We found that human
TSP bound: saturably to alli the plhsma lipoproteins tested.
Binding was maximal in the presence of 1 mM Ca"!Mg` and
was only, partlally inhibited'with 2 mM EDTA. RGD peptides
had no effect on binding. In eorttraati TSP binding to fibrino-
gen was completely ion dependent. The concentrations of TSP
that produced half maximal binding for VLDL HDL LDL,
apo Al. and apo All were 36.9, 1'24, 23.7; 6.9. and 18 nM.
respectively. These dala demonstrate that TSP camspecifically
interact with lipoproteins and suggest a potentia(!role for TSP
in the metabolism of lipoproteins, in their deposition into the
vessel walll and in atherogenesis.
r The Aasociatibn Betwcen Carotid Artctial Wall Thickness and
Acttve and Passive Cigarette Smoking
George Howard. Moyes Szklo. Gregory, Evans Grethe Tell,
John Eckfeldtl Gerardo Heiss, and the ARIC Investigators
Bowman Cray School of Medicine, Winston Salem. N.C.
The efiectof ciganette smoking on the carotid artery far wall
tliickneu was considered in the white population, from the
Atherosclerosis Risk in Communities (ARIC) study. The
population was divided into 2,460 current smokers, 3,48 pasn
smokcrs. 2,440 who never smoked but reported weekly cxpo
sure to environrnental cigarette smoke (ETS or "passive
smoking"),,and 1.306 who never smoked with no exposure to
ETS. Age proved to affect the differences between smoking
status classes (ps0.0001); while gender had no effect
(p>0:03). Within 5-year age groups there was a consistent
gradient of wall' thickness across the smoking exposure cate
gories (rteanzS,E. in millimeters):
Age
group No.
exposure
ETS only Past
smoker Current
smoker
i5-50 0,63_0.00h 0.66s0.0(]d 0.68zU.005 0.69x0.00h
St-55 o.G8=o.0ok n.69sn.006 0.75z0.ooc, 0.77=o.ooft
5tA-6ti 0.7! s0.007' 0.74=0.006 0.82=0.008 0-84sU.UlU
hl-ks 0.7720.011 o.78s0009 o.88x0.oa0 0.9U-0.015
Using analysis of covariance, differences between no exposure
and ETS were significant only at younger ages (p<0.0001),
while diflerences between ETS and past smoking, or between
past and current smoking, were significantonlr'for older ages.
This graded relationship underscores the importance of smok-
inR as a risk factor for atherosclerosis.
